Journal article

Detection of microdoses of rhEPO with the MAIIA test.

J Mørkeberg, K Sharpe, K Karstoft, MJ Ashenden

Scandinavian Journal of Medicine and Science in Sports | Published : 2014

Abstract

The detection of recombinant human erythropoietin (rhEPO) is difficult and becomes more challenging when only microdoses are administered intravenously. Twenty-three subjects were divided into two groups: EPO group (n = 7) and CONTROL group (n = 16). Seven urine and blood samples per subject were collected at least 5 days apart to determine within- and between-subject standard deviations in the percentage of migrating isoforms by the MAIIA test. Six injections of 50 IU/kg bw (boosting dosage) of epoetin beta (Neorecormon, Roche Diagnostics, Hvidovre, Denmark) were performed intravenously during a 3-week period, followed by two microinjections of only 10 IU/kg bw. Blood and urine samples were..

View full abstract

University of Melbourne Researchers